DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conference: Steven Pacelli, Executive Vice President, Strategy and Corporate Development, will present an update on the company...

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conference: Kevin Sayer, Chairman, Chief Executive Officer and President, will present an update on the company at the J.

DexCom, Inc. (Nasdaq: DXCM) ("DexCom") announced today that it intends to offer, subject to market conditions and other factors, $750 million aggregate principal amount of Convertible Senior Notes due 2023 (the "notes") in a private placement to qualified...

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conference: Steven Pacelli, Executive Vice President, Strategy and Corporate Development and Matthew Dolan, Vice President,...

DexCom, Inc. ( NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM), and Verily, an Alphabet company, announced an amendment to the Collaboration and License Agreement surrounding the ongoing development efforts between the companies.

DexCom, Inc. ( NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM), announced today the new Dexcom G6 ® CGM System will be covered for Medicare beneficiaries, having met the category requirements for therapeutic CGM systems by the U.

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conference: Quentin Blackford, Executive Vice President and Chief Financial Officer, and Matthew Dolan, Vice President,...

DexCom, Inc. ( NASDAQ:DXCM), the leader in continuous glucose monitoring for people with diabetes, announced today that Terry Gregg has retired as the Company's Executive Chairman and from the Company's Board of Directors after 13 years with Dexcom.